Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging

In clinical trials, biochemical markers provide useful information on the drug’s mode of action, therapeutic response and side effect monitoring and can act as surrogate endpoints. In pharmacological intervention development for sarcopenia management, there is an urgent need to identify biomarkers t...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ladang, Aurélie, Beaudart, Charlotte, Reginster, Jean-Yves, Al-Daghri, Nasser, Bruyère, Olivier, Burlet, Nansa, Cesari, Matteo, Cherubini, Antonio, da Silva, Mario Coelho, Cooper, Cyrus, Cruz-Jentoft, Alfonso J., Landi, Francesco, Laslop, Andrea, Maggi, Stefania, Mobasheri, Ali, Ormarsdottir, Sif, Radermecker, Régis, Visser, Marjolein, Yerro, Maria Concepcion Prieto, Rizzoli, René, Cavalier, Etienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859913/ https://www.ncbi.nlm.nih.gov/pubmed/36633611 http://dx.doi.org/10.1007/s00223-022-01054-z